Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.



Tragedy Drives AUM Founder Johnson to Develop Lifesaving Test

September 8, 2017

 

Tragedy Drives AUM Founder Johnson to Develop Lifesaving Test

Healthcare innovators and entrepreneurs often work at start-ups because they seek work with a purpose. Marie Johnson’s purpose found her in a most tragic way. Johnson, CEO and founder of AUM Cardiovascular, lost her husband, Rob, to a heart attack. He was 41, fit, and had just cleared a nuclear cardiology stress test. Prior to the tragedy, Johnson, then a 3M Fellow, worked with the Littman stethoscope unit to develop a computerized stethoscope. Her husband served as her sole subject in her study, enabling her to collect reams of data of his heart. In this interview, Johnson explains why she asked her husband to seek further testing and how she learned the gold standard test of the day fails to pick up an arterial blockage one third of the time. The day after the funeral, Johnson sat down and began sifting through the data. This search for answers led to a journey that took her and her young family to Italy, Stanford, and finally the corner office of a medical start-up. “I just knew his death was not by accident,” she said. “I knew I had to do something about this horrible condition.” Johnson used her insights, data, and talents to create the CADence System, a non-invasive, radiation-free, handheld tool to help assess the sounds associated with clinically significant coronary artery obstruction, congestive heart failure, and heart valve abnormalities. Her company, AUM Cardiovascular, secured FDA approval for CADence in August following a massive clinical trial. Now, the start-up faces the challenge of convincing physicians, clinical academies, and payers that CADence offers a faster, better, and cheaper way of uncovering the silent killer. Watch her TedxGullLake talk here.

 

Marie Johnson

Founder & CEO

AUM Cardiovascular

Dr. Marie Johnson, Ph.D. is an Advisor of TYLT Lab. She is the Founder, Chief Executive Officer, President and Director at AUM Cardiovascular, Inc. Prior to founding AUM Cardiovascular, Dr. Johnson created and led the University of Minnesota Medical Device Innovation Fellowship. She holds an adjunct faculty position and holds the medical device emphasis advisor position in Biomedical Engineering department at the University of Minnesota. Dr. Johnson has patents and patents pending in the United States, Europe, China, India and Taiwan in a broad range of disciplines including orthopedic, cardiovascular, ob/gyn, automotive, and food safety. She has 25 years of experience in product development and manufacturing in both Fortune 500 companies and university environments. Dr. Johnson holds a B.S. in Mechanical Engineering and a M.S. and Ph.D. in Biomedical Engineering and has completed three post-doctoral fellowships.

Meet Our Host, Geoff Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.